david siegel, md, phd, shares details from the apollo & candor trial updates presented at ash '20
Published 3 years ago • 30 plays • Length 2:28
Download video MP4
Download video MP3
Similar videos
-
1:23
david siegel, md, phd, elaborates on outcomes from the karmma trial
-
15:42
panoptix vs odyssey. which is better? doctor and patient perspective. great case! shannon wong, md
-
5:51
understanding selinexor: david siegel, md, phd
-
1:49
david siegel, md, phd, regarding the early test results of cc-220 presented at ash 2020
-
2:06
david siegel, m.d., phd, conducts critical research to develop new treatments for multiple myeloma
-
3:15
david siegel, md phd discusses myeloma highlights from ash 2018
-
2:58
david siegel, md, explains the results of mm014 study presented at ash
-
49:43
david siegel, m.d., phd mmrf conference podcast
-
53:05
stem cells, cell replacement, and parkinson's: a conversation with dr. roger barker
-
21:25
episode 22: dr. robert spetzler, neurosurgeon
-
4:34
why consider stem cell transplant for myeloma treatment: david siegel, md, phd
-
1:29
david siegel, md, phd, regarding bispecific antibodies in the management of relapsed/refractory mm
-
1:54
david siegel, md, phd, on pembrolizumab and lenalidomide in multiple myeloma treatment
-
1:10
dr. siegel on his presentation at ash
-
1:26
david siegel, md, phd, on the potential of ft538, an engineered, off-the-shelf nk therapy
-
1:01
david siegel, md, phd, on pomalidomide as an effective salvage therapy for mm patients
-
2:33
dr. siegel on new drugs discussed at ash
-
1:21
david s. siegel, md, discusses proteasome inhibitors and multiple myeloma
-
1:58
david cobrinik, md, phd, principal investigator in the saban research institute
-
1:30
david s. siegel, md, on how molecular profiling is helping drive treatment strategies
-
1:23
david siegel, md, phd, considers the effectiveness of car t-cell therapy in treating mm
-
4:36
ash 2018: using new drugs in the same drug class at multiple myeloma relapse
Clip.africa.com - Privacy-policy